AAM Rebuffs USTR Claims On Pricing Impact Of USMCA

 
• By Dave Wallace

USMCA – the renegotiated NAFTA trade deal between the US, Mexico and Canada – risks pushing up drug prices, the AAM has insisted in response to a USTR statement claiming the opposite.

Capsules
AAM And The USTR Disagree Over The Price Implications Of The USMCA • Source: Shutterstock

More from Regulation

More from Policy & Regulation